A Survey of Fear for Others, Fear for Self, and Pandemic Anxiety Predicting Intention to Take the First Booster Vaccine to Combat COVID-19.

A Survey of Fear for Others, Fear for Self, and Pandemic Anxiety Predicting Intention to Take the First Booster Vaccine to Combat COVID-19.

Publication date: Dec 31, 2023

This study examined the impact of fear and anxiety on the intent to take the first COVID-19 booster vaccine. The objective of this study is to provide guidance for messaging campaigns of public health practitioners. A survey approach provided insights about individuals’ emotions of fear and anxiety related to adopting the first booster vaccine for the Coronavirus disease 2019 (COVID-19). Three independent variables were considered in their ability to predict the intent to take the first COVID-19 booster vaccine (BINT): Fear for Others (FOTH), Fear for SELF (FSELF), and COVID-19 Anxiety (CANX). The confirmatory factor analysis supported an underlying three-factor solution for three central emotions in this study. A path analysis indicated significant direct effects for FOTH and FSELF in the prediction of BINT. The interdependent nature of these variables on the intent to get the first booster vaccine also was indicated by significant indirect effects. Fear should be more precisely refined to include the fear for others (FOTH) beyond consideration of the fear for self (FSELF) from the impact of COVID-19. FOTH and FSELF were demonstrated to be direct predictors of BINT. CANX was only found to be significant as part of indirect effects impacting BINT. Future investigation should be given to the mediating role of anxiety with FOTH and FSELF as the context changes.

Open Access PDF

Concepts Keywords
Basel COVID-19 anxiety
Coronavirus COVID-19 vaccination hesitancy
Pandemic fear for others
Refined fear for self
Vaccines

Semantics

Type Source Name
disease VO vaccine
disease MESH COVID-19
disease VO USA
disease VO vaccination
disease VO vaccinated
disease MESH communicable diseases
drug DRUGBANK Coenzyme M
disease VO vaccine efficacy
disease MESH death
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH influenza
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH infection
disease MESH uncertainty
disease MESH meningitis
drug DRUGBANK Spinosad
disease VO effectiveness
drug DRUGBANK Alpha-methyltryptamine
disease MESH complications
disease VO dose
disease IDO process
disease VO population
drug DRUGBANK Nonoxynol-9
disease VO Optaflu
disease VO effective
disease VO frequency
disease VO protocol
disease IDO site
disease VO vaccine clinical trial
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Guanosine
disease MESH Viral infection
drug DRUGBANK Delorazepam
disease MESH Asymptomatic infection
drug DRUGBANK Trestolone
disease IDO country
disease MESH causes of death

Original Article

(Visited 1 times, 1 visits today)